Enclosed

Poly Medicure reported FY26 consolidated revenue of Rs 1,875.3 Cr (up 12.3% YoY) and standalone revenue of Rs 1,662.5 Cr (up 3.8% YoY). Q4 FY26 standalone revenue hit a record Rs 443 Cr, while consolidated revenue reached Rs 534.5 Cr (up 21.3% YoY) aided by acquisitions of Citieffe and Pendracare Group. Standalone EBITDA margin came in at 26.8%, near the upper end of the 25-27% guidance range, with gross margins expanding by 130 bps due to product mix and cost optimization. Consolidated EBITDA margin was 24.4%, impacted by one-time acquisition costs of Rs 9.7 Cr and consolidation of acquired entities. The company holds strong liquidity of Rs 842.2 Cr and achieved ROIC of 21.4%. Key business updates include DEB commercial sales initiation, 450 dialysis machines sold, and acquisition of Brazil-based Medyneo for market access.